These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 16549518

  • 1. Transient reciprocal change of renal hepatocyte growth factor and transforming growth factor-beta1 may relate to renal hypertrophy in rats with liver injury or unilateral nephrectomy.
    Tsau YK, Tsai IJ, Chen YM.
    Pediatr Res; 2006 Apr; 59(4 Pt 1):494-9. PubMed ID: 16549518
    [Abstract] [Full Text] [Related]

  • 2. Nephromegaly relates to hepatocyte growth factor dysregulation in biliary atresia.
    Tsau YK, Jou ST, Ni YH.
    Pediatr Nephrol; 2002 Jul; 17(7):554-9. PubMed ID: 12172775
    [Abstract] [Full Text] [Related]

  • 3. Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice.
    Inoue T, Okada H, Kobayashi T, Watanabe Y, Kanno Y, Kopp JB, Nishida T, Takigawa M, Ueno M, Nakamura T, Suzuki H.
    FASEB J; 2003 Feb; 17(2):268-70. PubMed ID: 12475893
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte growth factor-induced amelioration in renal interstitial fibrosis is associated with reduced expression of alpha-smooth muscle actin and transforming growth factor-beta1.
    Wang HY, Wang YJ, Cui MJ, Gu CM, Yang LZ, Zhao Y, Chen Y, Zhao D, Li TS, Chi BR.
    Indian J Biochem Biophys; 2011 Oct; 48(5):308-15. PubMed ID: 22165288
    [Abstract] [Full Text] [Related]

  • 5. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.
    Mou S, Wang Q, Shi B, Gu L, Ni Z.
    Kaohsiung J Med Sci; 2009 Nov; 25(11):577-87. PubMed ID: 19858036
    [Abstract] [Full Text] [Related]

  • 6. Pathological changes, TGF-β1 expression, and the effects of hepatocyte growth factor in 5/6 nephrectomized rats.
    Wang HY, Yang LZ, Gu CM, Chen Y, Zhao Y, Zhao D, Li TS, Cui MJ.
    Ren Fail; 2014 Apr; 36(3):393-9. PubMed ID: 24345300
    [Abstract] [Full Text] [Related]

  • 7. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J, Dai C, Liu Y.
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [Abstract] [Full Text] [Related]

  • 8. Kidney volume and plasma hepatocyte growth factor-transforming growth factor beta1 ratio among children with biliary atresia before and after liver transplantation: the reversibility of nephromegaly.
    Cheng CH, Tsau YK, Tsai IJ.
    Am J Kidney Dis; 2005 Nov; 46(5):830-6. PubMed ID: 16253722
    [Abstract] [Full Text] [Related]

  • 9. Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors.
    Suh KS, Lilja H, Kamohara Y, Eguchi S, Arkadopoulos N, Neuman T, Demetriou AA, Rozga J.
    J Surg Res; 1999 Aug; 85(2):243-50. PubMed ID: 10423325
    [Abstract] [Full Text] [Related]

  • 10. Potent antioxidant role of pirfenidone in experimental cirrhosis.
    Salazar-Montes A, Ruiz-Corro L, López-Reyes A, Castrejón-Gómez E, Armendáriz-Borunda J.
    Eur J Pharmacol; 2008 Oct 24; 595(1-3):69-77. PubMed ID: 18652820
    [Abstract] [Full Text] [Related]

  • 11. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S, Nakamura T.
    Am J Physiol Renal Physiol; 2004 Jan 24; 286(1):F134-43. PubMed ID: 14519594
    [Abstract] [Full Text] [Related]

  • 12. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL.
    Gastroenterology; 2009 Jul 24; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [Abstract] [Full Text] [Related]

  • 13. Hepatocyte growth factor and transforming growth factor beta1 contribute to regeneration of small-for-size liver graft immediately after transplantation.
    Ninomiya M, Harada N, Shiotani S, Hiroshige S, Minagawa R, Soejima Y, Suehiro T, Nishizaki T, Shimada M, Sugimachi K.
    Transpl Int; 2003 Nov 24; 16(11):814-9. PubMed ID: 12879228
    [Abstract] [Full Text] [Related]

  • 14. Targeting TGF-beta1 increases hepatocyte growth factor (HGF/SF) levels in external auditory canal cholesteatoma (EACC) epithelial cell culture.
    Naim R, Chang RC, Alfano SS, Riedel F, Bayerl C, Sadick H, Bran G, Hormann K.
    Regul Pept; 2005 Aug 15; 130(1-2):75-80. PubMed ID: 15913806
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte 'priming' and increase in transforming growth factor-beta1 mRNA expression are delayed in hypothyroid versus euthyroid rats during liver regeneration.
    Moro L, Perlino E, Marra E, Greco M.
    Int J Mol Med; 2006 Jun 15; 17(6):1063-8. PubMed ID: 16685417
    [Abstract] [Full Text] [Related]

  • 16. Both Sp1 and Smad participate in mediating TGF-beta1-induced HGF receptor expression in renal epithelial cells.
    Zhang X, Yang J, Li Y, Liu Y.
    Am J Physiol Renal Physiol; 2005 Jan 15; 288(1):F16-26. PubMed ID: 15339794
    [Abstract] [Full Text] [Related]

  • 17. Regulation of c-met expression in rats with acute hepatic failure.
    Mizuguchi T, Kamohara Y, Hui T, Neuman T, Mitaka T, Demetriou AA, Rozga J.
    J Surg Res; 2001 Aug 15; 99(2):385-96. PubMed ID: 11469916
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
    Liu Z, Sakamoto T, Ezure T, Yokomuro S, Murase N, Michalopoulos G, Demetris AJ.
    Hepatology; 1998 Nov 15; 28(5):1260-8. PubMed ID: 9794910
    [Abstract] [Full Text] [Related]

  • 19. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
    Arias M, Sauer-Lehnen S, Treptau J, Janoschek N, Theuerkauf I, Buettner R, Gressner AM, Weiskirchen R.
    BMC Gastroenterol; 2003 Oct 18; 3():29. PubMed ID: 14565855
    [Abstract] [Full Text] [Related]

  • 20. Prevention of tissue injury by ribbon antisense to TGF-beta1 in the kidney.
    Choi YK, Moon IJ, Jung HK, Jang BC, Seo SI, Park JG.
    Int J Mol Med; 2005 Mar 18; 15(3):391-9. PubMed ID: 15702227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.